Skip to main content

par C367 Pill: beige orange, capsule/oblong, 19mm

The pill with imprint par C367 (Beige / Orange, Capsule/Oblong1) has been identified as Topiramate Extended-Release 100 mg and is used for Migraine Prevention, Lennox-Gastaut Syndrome, Epilepsy, Seizure Prevention, and Seizures. It belongs to the drug class carbonic anhydrase inhibitor anticonvulsants and is not a controlled substance.

Images for par C367

Topiramate extended-release 100 mg par C367

Topiramate Extended-Release

Imprint
par C367
Strength
100 mg
Color
Beige / Orange
Size
19.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical, Inc.
National Drug Code (NDC)
10370-0367

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.